Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study

[1]  S. Breit,et al.  Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. , 2002, BioTechniques.

[2]  Qingbo Xu,et al.  Smooth muscle cell apoptosis in arteriosclerosis , 2001, Experimental Gerontology.

[3]  Paul M. Ridker,et al.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. , 2001, The New England journal of medicine.

[4]  A. Nicolaides,et al.  The Genesis of Atherosclerosis and Risk Factors: A Review , 2001, Angiology.

[5]  W. D. Fairlie,et al.  Epitope mapping of the transforming growth factor-beta superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): identification of at least five distinct epitope specificities. , 2001, Biochemistry.

[6]  W. D. Fairlie,et al.  Macrophage inhibitory cytokine-1 (MIC-1) in epithelial neoplasia , 2001 .

[7]  R. Dean,et al.  Antioxidant properties of macrophages toward low-density lipoprotein. , 2001, Trends in cardiovascular medicine.

[8]  W. D. Fairlie,et al.  The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. , 2000, The Journal of clinical endocrinology and metabolism.

[9]  C. Arrowsmith,et al.  Placental Transforming Growth Factor-β Is a Downstream Mediator of the Growth Arrest and Apoptotic Response of Tumor Cells to DNA Damage and p53 Overexpression* , 2000, The Journal of Biological Chemistry.

[10]  P. Ridker,et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.

[11]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[12]  D. Givol,et al.  Profile of gene expression regulated by induced p53: connection to the TGF‐β family , 2000, FEBS letters.

[13]  K. Guan,et al.  PTGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway , 2000 .

[14]  K. Unsicker,et al.  Expression of a novel member of the TGF-β superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues , 1999, Cell and Tissue Research.

[15]  W. D. Fairlie,et al.  MIC‐1 is a novel TGF‐β superfamily cytokine associated with macrophage activation , 1999, Journal of leukocyte biology.

[16]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[17]  W. D. Fairlie,et al.  MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[19]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Circulation.